BANGALORE, July 29 (Reuters) - India’s Sun Pharmaceutical Industries Ltd (SUN.BO: Quote, Profile, Research) posted a sharp plunge in quarterly net profit on Wednesday, weighed down by the recent seizure of its unit’s medicines by the U.S. health regulator on manufacturing violations.
